Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
206
days
Integrative analysis of SLFN11-related DEGs reveals novel biomarkers for cisplatin sensitivity and immune modulation in colorectal cancer
Authors
Wei Wang; Lijiang Zhou; Jing Wang; Tingting Li; Zheng LiShow moreShow less
Affiliations
1. Department of Integrated Chinese and Western medicine, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China; 2. Department of Oncology, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China; 3. Traditional Chinese medicine oncology, Liaoning University of Traditional Chinese Medicine, Shenyang, ChinaShow moreShow less
74
days
The novel oleanolic acid derivative ZQL-4c modulates trastuzumab resistance in HER2+ breast cancer by inhibiting SCD-mediated lipid metabolism disorders
Authors
Yiwen Ma; Shisheng Wang; Xiaorui Li; Xiangyu Guo; Cui Jiang; Tao SunShow moreShow less
Affiliations
1. Breast Internal Medicine Ward 1, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China; 2. Breast Internal Medicine Ward 1, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China; 3. College of Pharmaceutical Science and Technology, Dalian University of Technology, Dalian, ChinaShow moreShow less
189
days
In silico repurposing of clinically approved drugs as potential BRAF inhibitors: a pharmacophore-based virtual screening and experimental investigation
Authors
Hooriehsadat Amini; Negin Ebrahimi; Sayedali Mousavirahimi; Mozhdeh Zamani; Kowsar Bagherzadeh; Hamed Montazeri; Homa AzizianShow moreShow less
Affiliations
1. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; 2. Protein Chemistry and Proteomics Laboratory, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran; 3. Student Research Committee, Iran University of Medical Sciences, Tehran, Iran; 4. Department of Pharmacognosy and Pharmaceutical Biotechnology, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran; 5. Eye Research Center, Five Senses Health Institute, Moheb Kowsar Hospital, Iran University of Medical Sciences, Tehran, Iran; 6. Lyon Cancer Research Center, Centre Léon Bérard, University Claude Bernard Lyon 1, INSERM U1052–CNRS UMR5286, Lyon, France; 7. Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran; 8. Artificial Intelligence in Health Research Institute, Iran University of Medical Sciences, Tehran, Iran; 9. Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, IranShow moreShow less
166
days
Global landscape of protein-coding and long non-coding RNA alternative splicing and regulation in the human esophageal squamous cell carcinoma
Authors
Yunfei Wang; Jingkuan Yang; Shuling Li; Yuanfang Zhang; Jingwei Xue; Shengyu Su; Ziyu Liu; Zhiying Zhao; Zhikun Feng; Qiong Wu; Zigang Dong; Kangdong Liu; Yanan JiangShow moreShow less
Affiliations
1. State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China; 2. The Pathophysiology Department, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China; 3. Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou, China; 4. Department of Pathology, People’s Hospital of Zhengzhou, Zhengzhou, China; 5. China-US (Henan) Hormel Cancer Institute, Zhengzhou, China; 6. Cancer Chemoprevention International Collaboration Laboratory, Zhengzhou, China; 7. Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou University, Zhengzhou, ChinaShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days